Cue Biopharma stockholders approve doubling authorized common stock to 200M shares

Cue Biopharma, Inc.

Authorized shares increased from 110M to 210M total, common from 100M to 200M.
Shareholders voted 29,291,818 for, 7,409,258 against, 499,006 abstain at Oct 8, 2024 special meeting.
Certificate of Amendment filed with Delaware Secretary of State on October 8, 2024.
No specific issuance plan disclosed; amendment provides flexibility for future capital needs.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Cue Biopharma, Inc.: Increased authorized shares of capital stock from 110,000,000 to 210,000,000 and authorized shares of common stock from 100,000,000 to 200,000,000 (effective 2024-10-08).

Change: charter amendment
Effective: 2024-10-08

Exact text from the filing

On October 8, 2024, Cue Biopharma, Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware effecting an amendment to increase the number of authorized shares of the Company’s capital stock from 110,000,000 to 210,000,000 and increase the number of authorized shares of the Company’s common stock from 100,000,000 to 200,000,000.

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Cue Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-113520

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.